7LH-21875-76416
3 vaccinations
1 coded response
31 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 201 / VA
- Registered
- 2021-04-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-28
Dose 1 — Pfizer-BioNTech
-
2021-04-29
Registered in v-safe
-
2021-04-29
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Joint pains, Fatigue or tiredness, NauseaAdult check-in
- 2021-04-30
-
2021-05-03
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Redness, Swelling, Itching · Headache, Fatigue or tiredness, NauseaAdult check-in
-
2021-05-04
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Redness, Itching · NoneAdult check-in
- 2021-05-05
- 2021-05-12
-
2021-05-19
Dose 2 — Pfizer-BioNTech
- 2021-05-19
-
2021-05-20
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-21
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tirednessAdult check-in
- 2021-05-23
- 2021-05-24
- 2021-06-09
- 2021-06-16
- 2021-06-23
- 2021-06-30
- 2021-08-18
- 2021-11-17
-
2021-11-18
Dose 3 — Pfizer-BioNTech
-
2021-11-19
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-11-20
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-11-21
- 2021-11-22
- 2021-11-23
- 2021-11-24
- 2021-11-25
- 2021-12-02
- 2021-12-09
- 2021-12-18
- 2021-12-23
- 2021-12-30
- 2022-02-17
-
2022-05-19
Survey response — 6 months, dose 3MedDRA: Adverse reaction, Blood pressure increased, Caesarean section, Headache, Paranasal sinus discomfort, Pre-eclampsia — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: Symptoms: Sinus pressure. Headache. C section. Post partum preeclampsia (high blood pressure). · Healthcare visit (other): For the preeclampsia. Other symptoms mild.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-19
Report sent to call center — 6 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalHospitalization · 1 call case(s)
- 2022-05-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-28 | Pfizer-BioNTech | |
| 2 | 2021-05-19 | Pfizer-BioNTech | |
| 3 | 2021-11-18 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-05-19 | Unsuccessful |
Free text
Release 11 — 6 months, dose 3
Symptoms: Sinus pressure. Headache. C section. Post partum preeclampsia (high blood pressure).
Healthcare visit (other): For the preeclampsia. Other symptoms mild.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Adverse reaction | · | · | ✓ |
| HCVO | Pre-eclampsia | · | · | ✓ |
| SD | Blood pressure increased | · | · | ✓ |
| SD | Caesarean section | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Paranasal sinus discomfort | · | · | ✓ |
| SD | Pre-eclampsia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release